Are circulating tumor cells (CTCs) a feasible tool for predicting disease recurrence and survival in nonmetastatic (M0) colorectal cancer (CRC)? This is an ASCO Meeting Abstract from the 2015 ...
"This study highlights that both subjective and objective assessments are necessary to get a full understanding of the clinical picture and guide treatment decisions."— Casey G. Kowalik, MD, FACS, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results